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Constitutive Expression of PU.1 in Fetal
Hematopoietic Progenitors Blocks T Cell
Development at the Pro-T Cell Stage
of PU.1. Thus, the role of PU.1 in T lineage differentiation
is currently unclear.
Recent data suggest subtle ways that PU.1 can con-
trol the timing and conditions of differentiation by posi-
tive or negative interaction with other transcription fac-
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Pasadena, California 91125 tors, including c-jun, Runx-1, Pip, Pax-5, and GATA-1
(Behre et al., 1999; Eisenbeis et al., 1995; Maitra and2 Stowers Institute for Medical Research
1000 East 50th Street Atchison, 2000; Petrovick et al., 1998; Rekhtman et al.,
1999). Like GATA-1 in erythroid cells, PU.1 upregulatesKansas City, Missouri 64110
transcription factors, growth factor receptors, and ef-
fector genes of myeloid cells (Nerlov and Graf, 1998;
Rothenberg et al., 1999) and can lock in its own expres-Summary
sion by positive autoregulation (Chen et al., 1995; Zhang
et al., 1996). It is therefore significant that PU.1 andThe essential hematopoietic transcription factor PU.1
GATA-1 can act as mutual inhibitors. For instance, inis expressed in multipotent thymic precursors but
progenitor cells facing an erythroid/myeloid lineagedownregulated during T lineage commitment. The sig-
choice, a shift in the balance of these factors can setnificance of PU.1 downregulation was tested using
up a cascade leading to dominance of one fate or theretroviral vectors to force hematopoietic precursors
other (Tenen et al., 1997; Nerlov et al., 2000; Rekhtmanto maintain PU.1 expression during differentiation in
et al., 1999; Zhang et al., 1999, 2000). Levels of PU.1fetal thymic organ culture. PU.1 reduced thymocyte
activity also appear to be critical in the B/macrophageexpansion and blocked development at the pro-T cell
fate decision (DeKoter and Singh, 2000).stage. PU.1-expressing cells could be rescued by
We and others have shown that PU.1 mRNA is ex-switching to conditions permissive for macrophage
pressed in the earliest thymic T cell precursors and isdevelopment; thus, the inhibition depends on both lin-
downregulated during the pro-T cell stage (Anderson eteage and developmental stage. An intact DNA binding
al., 1999; Spain et al., 1999). Strikingly, the shutoff ofdomain was required for these effects. PU.1 expres-
PU.1 expression, just before the CD44 CD25 stage,sion can downregulate pre-T, Rag-1, and Rag-2 in a
coincides with a loss of natural killer (NK) and thymicdose-dependent manner, and higher PU.1 levels in-
dendritic cell (DC) potentials, which are the last develop-duce Mac-1 and Id-2. Thus, downregulation of PU.1
mental alternatives of the common precursor to a T cellis specifically required for progression in the T cell
fate (Ikawa et al., 1999; Lucas et al., 1998). The last stagelineage.
at which PU.1 mRNA is expressed, the CD44CD25
stage, is also the last stage at which adult thymocytes
Introduction can be induced to develop into macrophages in vitro
(Lee et al., 2001). Several additional transcription factors
The regulatory program that guides hematopoietic pre- including Erg, Spi-B, and HEB-Alt are downregulated
cursors into T lineage differentiation is incompletely un- one stage later, after commitment, during the pro-T to
derstood. We are in the earliest stages of defining a pre-T transition that follows  selection (Anderson et al.,
network of transcription factors that direct commitment 1999; Anderson and Rothenberg, 2000). However, PU.1
to the T lineage. Genetic data indicate that one compo- is the only gene of 40 we have examined that under-
nent of the mechanism involved in T cell specification goes a clear shift in expression as thymic precursors
may be a well-known transcription factor of non-T cells, commit to the T lineage, which raises the question of
namely PU.1. PU.1 is essential for normal differentiation whether the timing of this downregulation is coincidental
of multiple hematopoietic lineages including B cells, or is a fundamental aspect of T lineage commitment.
macrophages, and granulocytes (Fisher and Scott, 1998; To address this question, we have used a retroviral vec-
McKercher et al., 1996; Scott et al., 1994). Its known tor to express PU.1 constitutively in fetal hematopoietic
target genes are used in the B and myeloid differentia- precursors, and we followed their differentiation in fetal
tion programs, with additional functions in stem cell- thymic organ culture (FTOC). Our results indicate that
like primitive progenitors (Scott et al., 1997). Therefore, PU.1 downregulation is essential for precursors to ad-
PU.1 would be expected to influence cells to differenti- vance beyond the pro-T cell stage.
ate along pathways that compete with the T lineage fate.
Detailed studies of the lymphoid cells of PU.1/ mice, Results
however, imply that this factor is required for efficient
generation of T cell precursors (McKercher et al., 1996; PU.1 Protein Expression in Adult and Fetal
Spain et al., 1999). Mature T cells belatedly appear in T Cell Precursors
postnatal PU.1/ mice, indicating that once cells pass In order to determine whether the PU.1 mRNA expres-
the pro-T stage they are no longer inhibited by a lack sion pattern observed during T cell development (Figure
1D) is maintained at the protein level, Western blot analy-
ses were performed on postnatal and fetal T cell precur-3 Correspondence: evroth@its.caltech.edu
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Figure 1. Western Blot Analyses of PU.1 Pro-
tein Expression
Protein blots were probed with anti-PU.1 anti-
body, stripped, and probed again with anti-
Sp1 antibody.
(A) Nuclear extracts from Rag-2/ thymo-
cytes (RT; lane 1), representing only pro-T
cells, and C57Bl/6 thymocytes (NT; lane 2),
representing mostly DP pre-T cells.
(B) E14.5 and E15.5 fetal thymocyte whole-
cell extracts at full strength (lanes 1 and 3)
and diluted by 1/3 (lanes 2 and 4).
(C) Mock-transduced (3  105 cells, lane 1)
or transduced fetal liver cells (GFP-FL, LZRS
as a control versus PU.1-FL) cultured for 72
hr with IL7 and SCF, and then sorted, at 9 
105 cells (lanes 2 and 5), 3  105 cells (lanes
3 and 6), or 1  105 cells (lanes 4 and 7).
(D) Diagram of T cell development, showing
that lineage commitment and downregulation
of PU.1 mRNA occur at the DN2 to DN3 transi-
tion, whereas  selection occurs at the DN3
to DN4 transition. The box indicates the DN
subsets that constitute the pro-T cell stage.
sor subsets (Figures 1A and 1B). These results indicate PU.1 protein levels in sorted populations of mock-
transduced, control-transduced, and PU.1-transducedthat postnatal pro-T cells, represented by Rag-2/ thy-
mocytes (RT; Figure 1A, lane 1), express elevated levels fetal liver-derived precursor cells were analyzed by
Western blot (Figure 1C). These results show that theof PU.1 protein as compared with normal thymocytes
(NT; Figure 1A, lane 2), which are comprised of at least PU.1-transduced cells express PU.1 protein at 1.5–3
times the level seen in control-transduced cells, which is95% cells past  selection. This pattern is replicated in
fetal T cell subsets, in that E14.5 fetal thymocytes, which roughly equivalent to the level seen in mock-transduced
cells (Figure 1C, lanes 1 and 3). Therefore, retroviralrepresent only CD4CD8 pro-T cells, express higher
levels of PU.1 protein than E15.5 fetal thymocytes (Fig- expression enabled PU.1 to be maintained constitutively
at levels similar to those in fetal-liver derived stem cellsure 1B). By E15.5, many thymocytes are past selection,
and 10%–20% have become CD4CD8 (data not and overexpressed as compared to normal fetal thymo-
cyte levels (data not shown). A direct measure of PU.1shown). Therefore, PU.1 protein is downregulated after
the pro-T cell stage in both postnatal and fetal T cell levels in the transduced cells once they had differenti-
ated in the fetal thymic lobes was impossible due to thedevelopment.
effect of PU.1 on the cell numbers.
Retroviral Expression of PU.1 in Fetal Liver-Derived
Hematopoietic Precursors Constitutive Expression of PU.1 during T Cell
Development Results in Growth InhibitionTo examine the importance of PU.1 downregulation in
early thymic precursors, hematopoietic precursors were and an Arrest at the Pro-T Cell Stage
PU.1 expression inhibited donor cell expansion in FTOCobtained from E14.5 fetal liver cells, stimulated over-
night, and infected with bicistronic retroviral vectors en- as compared to controls, with 10 lower frequencies
of GFP cells recovered at 1 week of culture (Figurecoding either GFP alone (LZRS, as a control), or PU.1
plus GFP. PU.1-transduced fetal liver cells typically 2A) and 50 lower frequencies recovered at 2 weeks
(Figure 2B). This inhibition was coupled with a strongshowed 1–3 times higher levels of GFP fluorescence
than LZRS controls at the time of sorting (data not differentiation block. By 2 weeks in culture, many of the
control GFP cells had progressed from the immatureshown). GFP cells were sorted, incubated in hanging
drop culture with deoxyguanosine-treated fetal thymic CD4CD8 (double-negative, DN) stage to the immature
CD8 and CD4CD8 (double-positive, DP) stages, andlobes, and maintained in standard FTOC for up to two
weeks. Donor cells were distinguished by the Ly5.1 al- a few had differentiated into more mature CD4 or CD8
single-positive (SP) cells (Figure 2C). The PU.1-trans-lele. In each culture, about half of the cells silenced
expression from the retroviral vector at an early stage duced cells, in contrast, were almost completely re-
stricted to the DN stage. Furthermore, some controlafter sorting, providing an internal Ly5.1GFPcontrol
population. The GFP cells transduced with the LZRS cells had become  T cells (TCRCD3) or  T cells
(TCRCD3), whereas PU.1-transduced cells gener-control vector mimicked the development of the GFP
cells, and the GFP cells in each culture developed ated neither of these populations (Figures 2D and 2E).
Reaggregate FTOCs, in which transduced cells werenormally in almost every respect (data not shown).
Stage-Specific Block of T Cell Development by PU.1
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Figure 2. Effects of PU.1 and HEB-Alt on Fetal Liver Precursor Differentiation in Fetal Thymic Organ Culture
Fetal liver precursors infected with the Lazarus retrovirus as a control (LZRS-GFP), a PU.1-encoding LZRS retrovirus (PU.1-GFP), or an HEB-
Alt-encoding LZRS retrovirus (HEB-GFP) were differentiated in fetal thymus organ culture (FTOC) and analyzed for expression of differentiation
markers by FACS analysis. GFP versus Ly5.1 expression gated on live cells after (A) 8 days and (B) 13 days in FTOC. The percentages of
GFP cells are indicated. (C) and (D) are gated on GFP cells at day 13 of FTOC. The CD3TCRcells represent  T cells. (E) provides a
diagram of T cell differentiation from hematopoietic stem cells (HSC) and indicates the timing of the PU.1 block. Broken circles indicate cell
populations lost in the presence of retroviral PU.1. The thick bar indicates a complete block in differentiation.
mixed directly with stroma, gave very similar results using an isoform with an alternative promoter (HEB-Alt)
that is transiently expressed in pro-T cells (Anderson et(data not shown), indicating that the decrease in cell
number in the PU.1 samples was not simply due to an al., 1999; Anderson and Rothenberg, 2000; Rothenberg
et al., 1999). HEB-Alt, retrovirally expressed in fetal liverinability of the cells to migrate efficiently into the thymic
lobes. precursors using the same vector, reproducibly inhibited
proliferation to a similar degree as PU.1 in the first weekThe differentiation block was specific to PU.1 and not
mimicked by retroviral expression of other transcription of FTOC (2% GFP cells with HEB-Alt versus 3% GFP
with PU.1). However, HEB-Alt transduced cells were notfactors with antiproliferative effects (Figure 2 and un-
published observations). Figure 2 shows, for compari- further inhibited in proliferation in the second week of
culture, and they efficiently generated DP and SP thymo-son, the effects of the bHLH transcription factor HEB,
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Figure 3. Effects of PU.1 Expression on Early T Cell Development
Fetal liver precursors infected with the LZRS retrovirus as a control (LZRS-GFP) or a PU.1-encoding retrovirus (PU.1-GFP) were differentiated
in fetal thymus organ culture for 1 week and analyzed for expression of GFP, CD44, and CD25 by FACS analysis.
(A) CD44 versus CD25 expression gated on GFP cells.
(B) Analysis of retroviral expression level as a function of developmental stage. Abbreviations: MFI, mean GFP fluorescence intensity; DN1,
CD44CD25; DN2, CD44CD25; DN3, CD44CD25.
(C) Diagram of T cell development with the early subsets expanded into three distinct populations. Broken circles indicate cell populations
lost in the presence of retroviral PU.1. The thick bar indicates a complete block in differentiation, and the thin broken bar indicates partial
inhibition as inferred from lower GFP fluorescence levels in surviving cells.
cytes. Furthermore, both  T cells and  T cells which normally have just shut off endogenous PU.1
mRNA expression (Anderson et al., 1999). Retroviralemerged in the HEB-Alt cultures. Thus, the complete
block at the DN to DP transition for cells expressing PU.1 PU.1 expression was deleterious to the more differenti-
ated cells, however, as shown by the reduced intensityis not simply an artifact of its antiproliferative effects.
of PU.1-linked GFP fluorescence as a function of devel-
opmental stage, suggesting a selection for cells ex-PU.1 Expressing Precursors Differentiate
pressing lower PU.1 levels. GFP fluorescence, by con-to the CD25 Pro-T Cell Stage
trast, did not decrease to the same extent in controlIn contrast to the differentiation arrest observed in later
samples (Figure 3B). Too few NK1.1 cells were pro-stages, PU.1-transduced cells progressed through most
duced in the experiments in which the NK1.1 markeror all of the pro-T cell stages leading to  selection, i.e.,
was monitored directly to reliably assess whether theup to the DN3 stage (see Figures 1D and 3C). Examples
generation of these cells was selectively enhanced orof GFP cells analyzed after 1 week of culture from two
inhibited by PU.1 expression.experiments are shown in Figure 3. The cell yields were
low and the expansion of PU.1-expressing cells variable
from experiment to experiment. However, the identity Effects of PU.1 on T Cell Development Require
an Intact DNA Binding Domainof PU.1-expressing CD25 pro-T cells in every culture
was further substantiated by analyses of Thy-1 and/or PU.1 can exert its effects through any of several distinct
domains that separately mediate DNA binding, trans-Sca-1 and NK1.1 expression (data not shown). More-
over, the PU.1-transduced cells sometimes included a activation, and interaction with specific protein partners
(Tenen et al., 1997). A mutation in the ETS DNA bindingsubstantial percentage of CD44CD25 (DN3) pro-T cells,
Stage-Specific Block of T Cell Development by PU.1
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Figure 4. Expression of the Non-DNA Binding PU.1-215 Mutant Does Not Inhibit T Cell Development
Fetal liver precursors were infected with either a PU.1-encoding retrovirus (PU.1-WT-GFP) or a mutant PU.1-encoding retrovirus (PU.1-215-
GFP) that cannot bind DNA. GFP cells were sorted, differentiated in fetal thymic organ culture, and then analyzed by FACS after (A) 1 week
or (B) 2 weeks. All plots in (A) are gated on GFP cells. The upper plots in (B) are gated on live cells, whereas the lower plots are gated on
GFP cells. The pro-T cells in (A) are represented by the CD25Thy-1 population. Quadrant percentiles are indicated.
domain that changes the tryptophan at position 215 to a guished by their Ly5.1int phenotype (Figure 2A), the ex-
pression of B220 and/or CD19, and the lack of Thy-1glycine (PU.1-215) abolishes DNA binding (Kodandapani
et al., 1996). To find out whether the effects of constitu- (Figures 5A and 5B). In all cases where B lineage cells
were present in the GFP control samples, they weretive PU.1 expression require DNA binding, we generated
a PU.1-215 retroviral construct and compared its effects completely absent from the PU.1-expressing samples.
These results were confirmed when fetal liver-derivedon T cell development with those of wild-type PU.1
(PU.1-WT). PU.1-215 transduced cells expressed PU.1 precursors were tested in high oxygen submersion
FTOC (HOS-FTOC) supplemented with cytokines (Figureprotein at levels comparable to PU.1-WT-transduced
cells (data not shown). After 1 week of culture, the PU.1- 5C). These conditions allow the generation of Thy-1 (T
lineage), B220 (CD45R, B lineage), and Mac-1 (CD11b,WT cultures contained 2,380 GFP cells/lobe, as com-
pared with 11,840 GFP cells/lobe in the PU.1-215 cul- myeloid lineage) cells at the same time (Kawamoto et
al., 1997), as shown in Figure 5. Under these conditions,tures. Even in this experiment, in which an unusually
high percentage of GFP cells survived, expression of PU.1 expression sharply reduced the numbers and per-
centages of Ly5.1int (Figure 5E), CD19 (Figure 5C), andPU.1-WT still limited proliferation and prevented genera-
tion of DP or SP cells in the second week (Figure 4). In Thy-1 (Figures 5C, 5F, and 5G) cells as compared to
the controls. These results verify that the levels of PU.1contrast, the PU.1-215 expressing cells proliferated well
(Figure 4A), including those in the Thy-1, CD44, and expression achieved in these precursors were sufficient
to block B cell differentiation even in a permissive sys-CD25 late pro-T cell stage. Furthermore, the PU.1-215
mutant allowed full differentiation of precursors into DP, tem, and did not divert the T cell precursors into a B
lineage fate (Figure 5H). Furthermore, Ly5.1intGFP cellsCD4-SP, and CD8-SP subsets by the second week of
culture (Figure 4B). These results show that the interfer- failed to develop in these cultures as well, indicating
that even cells that had shut off retroviral expressionence of PU.1 with proliferation and differentiation of T
lineage cells depends on the integrity of its DNA binding after sorting could not differentiate into the B lineage
(Figure 2A).domain.
PU.1 Expression Blocks B Cell Development Constitutive PU.1 Expression Promotes
Macrophage Developmentat a Very Early Stage
Sustained overexpression of PU.1 has been shown to Although constitutive PU.1 expression had devastating
effects on T and B lineage cells, expression of PU.1 inabort B cell development in a dose-dependent way (De-
Koter and Singh, 2000). To compare the sensitivities of this system is not generally toxic to hematopoietic cells.
A much greater fraction of PU.1-expressing GFP cellsT cell development and B cell development to constitu-
tive PU.1 expression, B cell precursors were tracked survive in HOS-FTOC than in normal FTOC (Figures 2A
and 5E). Whereas modest percentages of Mac-1high andusing the markers CD19 and B220 (Figure 5). B lineage
precursors differentiated from fetal liver precursors in F4/80 cells were generated in HOS-FTOC in the GFP
control samples, these constituted the overwhelmingconventional FTOC in occasional experiments, distin-
Immunity
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Figure 5. Effects of PU.1 Expression on B and Myeloid Lineage Cells
Several representative experiments are shown. Fetal liver precursors infected with the LZRS retrovirus as a control (LZRS-GFP) or a PU.1-
encoding retrovirus (PU.1-GFP) were differentiated in (A) fetal thymus organ culture (FTOC) plus IL-7 and stem cell factor for 7 days, (B)
conventional FTOC (no cytokines added) for 8 days, or (C, F, and G) high oxygen submersion (HOS) FTOC culture plus IL-7, IL-3, and SCF
for (C) 9 or (E–G) 10 days, and then analyzed by flow cytometry. All samples are gated on GFP cells except (E), which shows the percentages
of GFP cells under HOS conditions using a live scatter gate. Percentages are indicated for each quadrant. (E) Absolute number of GFP
cells per lobe in the categories listed. The FACS analyses in (E)–(G) contain pools of 1 1/2 lobes each. (H) Diagram of effects of PU.1 on T cell,
B cell, and macrophage fate choices. Broken circles indicate cell populations lost in the presence of retroviral PU.1, the thick black circle
indicates a bias toward the macrophage fate, and the bars indicate inhibition of these fates.
majority of the PU.1-expressing cells (Figures 5D, 5F, Rescue of PU.1-Expressing Cells Arrested at the DN
Stage by Transfer into HOS-FTOCand 5G). By contrast, macrophages were never ob-
served to develop in conventional FTOC from either con- The poor survival of PU.1-expressing cells, even in the
primitive CD44CD25 population, in conventionaltrol or PU.1-expressing precursors (data not shown).
The absolute number of myeloid cells produced by the FTOC raised the question of whether these cells are
irrevocably condemned to die within a certain time, orPU.1-expressing populations is similar to that produced
by the control GFP-expressing populations, in sharp whether they preserve the potential to be rescued by
diversion into another developmental pathway. To trycontrast to the lymphoid cell types (Figure 5D). Further-
more, the PU.1-expressing cells showed a higher average to rescue these cells, control or PU.1-expressing fetal
liver-derived precursors were cultured in FTOC for 5level of expression of both Mac-1 (Figure 5F) and F4/80
(Figure 5G), suggesting a more mature macrophage phe- days and then transferred into HOS-FTOC supple-
mented with cytokines for an additional 10 days of cul-notype. Therefore, the detrimental effects of PU.1 expres-
sion on both cell number and differentiation state are ture (Figure 6). The initial 5 days in conventional FTOC
resulted in an expansion of T cell precursor activity in thespecific to the T and B lymphoid lineages and are not
due to a nonspecific toxic effect. Furthermore, the mean GFP control samples, with a corresponding depletion of
cells that could give rise to Mac-1high descendants. Asfluorescence intensities of Mac-1, F4/80, and GFP are
all higher in the PU.1-expressing myeloid cells (data not in conventional FTOC and HOS-FTOC alike, PU.1-
expressing precursors generated severely reducedshown), indicating that PU.1 actually promotes macro-
phage development in collaboration with the appro- numbers of T lineage (Thy-1) and B lineage (CD19)
cells (Figure 6C, and data not shown). However, the shiftpriate growth factors.
Stage-Specific Block of T Cell Development by PU.1
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Figure 6. Switching PU.1-Expressing Progenitors from FTOC to HOS Conditions Can Result in Rescue into the Myeloid Lineage
(A) FACS analysis of precursors expressing PU.1 and GFP or the LZRS-GFP (control) after 5 days in FTOC, gated on live cells. These lobes
were then either switched to HOS conditions for 10 days or maintained in FTOC for an additional 5 days. Percentiles for each quadrant are
indicated. These FACS plots represent pools of 3 lobes each for the PU.1 samples, and 1–2 lobes for the control GFP samples.
(B) Diagrammatic representation of the experimental protocol showing the effects of PU.1 expression at each stage. Symbols are as in Figure 5.
(C) Absolute numbers of GFP cells per lobe after 5 days in FTOC, 10 days in FTOC, or 10 days after the switch to HOS conditions (rescue).
ND indicates not determined.
to HOS culture completely arrested the decline in the ined after 24 hr by flow cytometry (Figure 7A). A higher
proportion of the PU.1-expressing thymocytes exhibitedoverall percentage of PU.1-expressing cells relative to
controls and allowed an 8-fold expansion in absolute surface Mac-1 expression. The GFPMac1 cells con-
tained both CD25 and CD25 subsets (data not shown).numbers. A greatly elevated proportion of these PU.1-
expressing cells were Mac-1 (32%–64% in two experi- In the PU.1-GFP-transduced samples, the Mac-1 cells
expressed higher levels of GFP than the Mac-1 cells,ments) as compared to the control cultures (1%–2%
Mac-1/Thy-1) in the rescued samples. The levels of indicating a threshold dose effect. These cells were also
examined for the presence of CD115, the macrophageMac-1 and the variable F4/80 expression phenotypes
of these cells (data not shown) are not equivalent to colony stimulating factor receptor (M-CSFR). Although
both the control and PU.1-expressing samples con-those of PU.1-transduced cells differentiating in HOS-
FTOC from the start (Figure 5), suggesting that a variety tained CD115Thy-1 cells, only the PU.1-transduced
samples exhibited upregulation of CD115 on some ofof myeloid fates remain open to cells in the thymus that
express PU.1. These results indicate that some PU.1- the Thy-1 cells. Furthermore, the absolute numbers of
GFPMac-1 and GFPCD115Thy-1 cells were greaterexpressing cells in FTOC are arrested rather than com-
mitted to die irreversibly and can be rescued into an in the PU.1-expressing sample than in the control sam-
ple (Figure 7B). These results indicate that PU.1 canalternative lineage given the proper conditions.
specifically induce myeloid genes in thymic precursors.
The tiny numbers of PU.1-expressing cells that survivePU.1 Modulation of Gene Expression in Fetal
Thymocytes and SCID.adh Cells in fetal thymic organ culture prohibit a direct analysis
of mRNA levels in this system. We used the SCID.adhTo determine whether PU.1-overexpressing thymocytes
can acquire myeloid characteristics, E14.5 fetal thymo- cell line (Carleton et al., 1999), which represents pro-
T cells at the CD44CD25 stage and does not normallycytes were transduced with control or PU.1-GFP vec-
tors, cultured overnight with IL-7 and SCF, and exam- express PU.1, to define changes in specific gene expres-
Immunity
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Figure 7. Ectopic PU.1 Expression Can Alter Gene Expression in Primary Thymocytes and the SCID.adh Cell Line
(A) E14.5 fetal thymocytes were transduced with LZRS-GFP (control) or PU.1-GFP retroviral vectors, cultured for 24 hr in 25 ng/mL IL-7 and
2% stem cell factor, and analyzed by FACS. All flow cytograms are gated on live, GFP cells. CD115 indicates macrophage colony stimulating
factor.
(B) Absolute numbers of GFP cells per lobe for each phenotype category.
(C) SCID.adh cells were transduced with control or PU.1-GFP retroviral vectors, cultured, and sorted on the basis of GFP and/or Mac-1 surface
expression. This panel shows the relative values of mRNA levels for PU.1 in each sample as determined by real-time RT-PCR for three separate
experiments.
(D) Changes in mRNA levels in control-transduced SCID.adh cells, PU.1-transduced Mac-1 SCID.adh cells, and PU.1-transduced Mac-1
SCID.adh cells in one representative experiment, as assessed by quantitative real-time PCR. The results are presented as ratios of PU.1Mac-
1/Control (blue bars) and PU.1Mac-1/Control (red bars), on a logarithmic scale. Each set of relative values, calculated using a standard
curve specific for each primer set, has been normalized to GAPDH mRNA levels.
sion induced by forced retroviral expression of PU.1. three. In the PU.1Mac-1cells, there was a slight induc-
tion of Mac-1 mRNA and a slight decrease in Rag-1,Control-transduced or PU.1-transduced SCID.adh cells
were cultured for variable amounts of time, sorted, and Rag-2, and pre-T mRNA in comparison with the con-
trols. In the PU.1-transduced cells that expressed Mac-1examined for surface phenotype by flow cytometry (data
not shown) and for mRNA levels by quantitative real-time on the surface, however, these effects were magnified,
including an almost complete shut-off of Rag-1, Rag-2,RT-PCR (Figures 7C and 7D). After PU.1 transduction, a
variable percentage (5%–45%) of SCID.adh cells ex- and pre-T. Interestingly, Id-2 was upregulated only in
the Mac1 cells, and these cells also exhibited an ap-pressed Mac-1, whereas no Mac-1 was seen on the
control-transduced cells or the untransduced cells (data proximately 2-fold increase in the PU.1 mRNA level,
further supporting the idea of a PU.1 threshold effect.not shown). The PU.1-transduced SCID.adh cells contin-
ued to express CD25 as well as Thy-1, indicating that Amplification of the PU.1 untranslated region, which is
not contained within the retroviral construct, indicatedthe cells are not being induced to transition through the
 selection checkpoint. The PU.1Mac-1 cells were that retroviral PU.1 did not induce the endogenous PU.1
gene in the SCID.adh cells (data not shown). The poten-sorted, and their RNA expression was analyzed in paral-
lel with sorted PU.1Mac-1 cells and sorted GFP tial ability of increased levels of Id-2 to inhibit E2A-
mediated induction of Rag-1, Rag-2 (Zarrin et al., 1997),LZRS-transduced cells.
Figure 7D shows the impacts of PU.1 on SCID.adh and pre-T (Takeuchi et al., 2001) provides one potential
component of the mechanism for the developmentalgene expression in one representative experiment of
Stage-Specific Block of T Cell Development by PU.1
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block at the pro-T cell stage. However, the less-dramatic as many cells in the thymic microenvironment as the T
lineage program. Third, PU.1 overexpression may putinhibition of these genes in the PU.1Mac1 cells, which
the cells at a severe disadvantage in competition fordo not display a significant increase in Id-2, indicates
limiting growth or survival niches as compared to thethat other mediators are required for these effects. Pre-
nonexpressing cells, which are unavoidably generatedliminary results from SCID.adh cells and primary fetal
in our cultures by retroviral vector silencing. Our datathymocytes transduced with PU.1 indicate that two ad-
give evidence that all three mechanisms may contributeditional transcription factors known to be essential in
to these effects. Clonal assays of PU.1-transduced cellsearly T cell development, Myb and Hes-1, are also down-
are underway to resolve conclusively how much eachregulated by PU.1. Further experiments in primary thy-
of these mechanisms contributes (A.H.W. and E.V.R.,mocytes will be necessary to confirm these results and
unpublished data).discover the nature of the physical interactions between
It is important to note that the antiproliferative effect,these genes and their protein products.
as well as the specific blockade of T cell differentiation
depends on the integrity of the PU.1 DNA binding do-Discussion
main. This suggests that PU.1 blocks T cell development
in this system by driving the expression of particularThis work shows that the programmed downregulation
target genes that arrest the T cell program and not byof PU.1 expression that occurs in pro-T cells is essential
merely interfering with other T cell transcription factors.for continued progress through T lineage differentiation.
This hypothesis is supported by the downregulation ofForced expression of PU.1 most severely blocks the DN
pre-T, Rag-1, and Rag-2 and the upregulation of Id-2to DP transition and the generation of TCR cells, both
in PU.1-transduced SCID.adh cells in a dose-dependentof which normally occur just after the pro-T cell stage.
manner. Id-2 is normally present at high levels in theThis selective effect can be seen even over a back-
earliest thymic precursors and is downregulated toground of general inhibitory effects of PU.1 on lymphoid
lower levels at the DN1 to DN2 transition (M.K.A., unpub-proliferation and survival. Most importantly, these inhibi-
lished data), at which time Rag-1 and pre-T are inducedtory effects are completely dependent on develop-
(Rothenberg et al., 1999). Ectopic expression of Id-2mental stage and lineage choice. Cells differentiating
at the DN3 stage may interfere with the E2A-mediatedinto the myeloid lineage are unaffected, and precursors
transcription of the recombinase and pre-Tgenes, thusthat have already been subjected to 5 days of inhibited
rendering the cells incapable of synthesizing the pre-T celldevelopment under T lineage promoting conditions can
receptor complex necessary for progression through recover efficiently if switched to myeloid-permissive
selection. It should be emphasized, however, that aconditions.
slight decrease in Rag-1, Rag-2, and pre-T were evi-Our results establish a dose-response contour for
dent in the PU.1Mac-1 cells, which did not containPU.1 that distinguishes among myeloid cells, early
elevated Id-2 levels. Therefore, the effects of PU.1 onB cells, early T lineage precursors, and cells passing
gene expression in these cells are not mediated solelythrough the transition from pro-T cell to DP or TCR
through Id-2. Recent results in PU.1-transduced fetal
stages. All the lymphoid cell types monitored here are
thymocytes also show effects on Hes-1 and Myb expres-
adversely affected to some degree by PU.1; however,
sion, indicating that PU.1 acts at multiple nodes of the
the tolerance of early T cell precursors to PU.1 overex-
transcriptional network that guides precursors into the
pression suggests a positive role for this factor in these T cell lineage (M.K.A. et al., unpublished data).
cells. This tolerance diminishes with progress through PU.1 is likely to promote survival of committed my-
the CD25 (pro-T) stage, as shown by the lower GFP eloid precursors selectively, but a notable result is that
fluorescence of the surviving cells, and collapses in the it also appears to permit some myeloid-type genes to
transitions leading to DP or TCR stages. Finally, PU.1 be expressed in cells within the T lineage program. This
overexpression is incompatible with passage through is seen not only in the SCID.adh cell line but also to
these TCR-dependent checkpoints. some extent in the Thy-1 fetal thymocytes. It remains
Direct analysis of control-transduced and PU.1-trans- to be determined whether any of these myeloid genes
duced fetal liver cells indicates that they accelerate dif- could be causing the disruption of T cell development.
ferentiation toward the myeloid (Mac-1high/CD115) fate One PU.1 target gene of special interest could be the
in culture, which could reduce the number of precursors GM-CSFR gene (Hohaus et al., 1995). Forced expression
available for colonization of the thymus (A.H.W., M.K.A., of this gene in thymocytes causes a GM-CSF-dependent
and E.V.R., unpublished results). The precursors that block of T cell development that is strikingly similar to the
can repopulate the thymus are further blocked at the results reported here (Yasuda et al., 1997). The induction
pro-T cell stage, suggesting two distinct stages of PU.1 of Mac-1 and M-CSFR in fetal thymocytes in response
interference with differentiation toward the T cell lin- to high levels of PU.1 suggests a threshold over which
eage. Beyond that, three kinds of cellular mechanism a partial activation of a myeloid lineage program can
could be responsible for the inhibitory effects of PU.1 occur. Studies to investigate the possibility that induc-
on cell growth. First, elevated levels of PU.1 may directly tion of myeloid growth factor receptors can modulate
cause the death of cells in particular developmental the survival and/or expansion of the PU.1-expressing
states, as has been reported in some erythroid lineage precursors in the thymic microenvironment are currently
cells (Yamada et al., 1997). Second, PU.1 might divert underway.
cells from the T lineage differentiation program to an- PU.1 could also block T cell development in part by
other, e.g., a dendritic cell program, which could mimic interfering with the function of the essential T cell factor
GATA-3 (Ting et al., 1996), analogous to its effects onan antiproliferative effect because it does not generate
Immunity
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lected after 24 and 48 hr and immediately stored in 3 ml aliquotserythroid development through GATA-1 (Nerlov et al.,
at 70	C until use.2000; Rekhtman et al., 1999). Although we do not see
Fetal liver cells obtained from E14.5 Ly5.1-C57Bl/6 embryos werea decrease in the mRNA levels of GATA-3 as a result of
depleted of Ter119 and Gr-1 cells by magnetic column separation
retroviral PU.1 expression in the SCID.adh cells (data (Miltenyi Biotec) and then cultured in DMEM-FTOC (DMEM, 10%
not shown), this does not preclude a posttranslational FCS, 1X L-glutamine, 100 unit/mL penicillin, 100 
g/mL streptomy-
cin, 1% nonessential amino acids, 50 
M  mercaptoethanol, 20inhibition of function (Zhang et al., 2000). In other experi-
mM HEPES) with recombinant IL-7 (25 ng/mL) and stem cell factorments, we have observed a shift in the effect of GATA-3
(SCF, 2% BHK-MKL supernatant) overnight. The cells were spinoverexpression at the pro-T to pre-T transition that is
infected with 3 ml retroviral supernatant and then cultured for 40–48the reverse of the effect of PU.1 (G.H.-H., M.K.A., and
hr in DMEM-FTOC with IL-7 and SCF. GFP cells were sorted by
E.V.R., unpublished data). It might be possible that the flow cytometry.
combination of low-level PU.1 and GATA-3 is required Fetal thymic lobes were obtained from E14.5 C57Bl/6  DBA/2
F2 embryos and digested in 1 mg/mL T4 collagenase (Worthington)for the expression of certain genes necessary to the
at 37	C for 30 min. The cells were infected with retroviral supernatantpro-T cell stage, whereas the pre-T cell and  T cell
and cultured for 24 hr in IL7 and SCF, as described for fetal liverexpression programs require GATA-3 in the absence of
cells above. SCID.adh cells were infected in the same way as thePU.1.
primary cells and were maintained under normal culture conditions
A critical result of this work is to link the downregula- for 2 days (Figure 7C, experiment 2, and Figure 7D), 4 days (Figure
tion of PU.1 expression causally with the mechanism of 7C, experiment 3), or sorted after 24 hr for GFP cells and then
cultured for 12 days (Figure 7C, experiment 1). Each of these experi-T lineage commitment. PU.1 stood out in our surveys
ments was conducted using a different batch of SCID.adh cells, allof gene expression changes as the one gene studied
of which were Thy-1, CD25, and CD44, infected on differentthat experienced a sharp regulatory change just at the
days.transition coincident with T lineage commitment (Ander-
son et al., 1999; Rothenberg, 2000; Rothenberg et al.,
Western Blot Analysis
1999). Some mechanism acting upstream to regulate Thymocytes were obtained from Rag-2/ mice, C57BL/6 (normal)
PU.1 itself must coincide in time with the T lineage com- mice, or E14.5 and E15.5 C57BL/6  DBA/2 F2 embryos. Stem cell-
mitment mechanism, but it was not clear from that coin- enriched cultured fetal liver cells were transduced with LZRS-GFP
or PU.1-GFP as above, cultured for 72 hr, and sorted for GFP expres-cidence alone whether the PU.1 regulatory mechanism
sion. Cells mock-transduced with media were sorted on a live scatterhad anything to do with commitment. Here, by showing
gate. Whole-cell extracts were prepared as follows: cells werethat PU.1 must be downregulated for T cells to differenti-
washed once with 1 PBS, and pellets were placed on dry ice for
ate beyond the pro-T stage, we provide evidence that 15 min. Pellets were thawed and resuspended in Buffer C (20 mM
that mechanism is indeed a component of the T lineage HEPES, 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol)
commitment process, one that is required to allow T plus fresh 1 CompleteTM protease inhibitor cocktail (Boehringer-
Mannheim). Pellets were vortexed for 2 min at 4	C and spun for 10committed cells to survive. Thus, PU.1 itself provides
min at 4	C. Nuclear extracts were prepared as follows: cells wereone of the target genes acted on by the T lineage com-
suspended in Buffer A (10 mM HEPES [pH 7.9], 10 mM KCl, 0.1 mMmitment mechanism.
EDTA, 0.1 mM EGTA, 1 mM dithiothreitol) plus 1 protease inhibitor
cocktail and incubated on ice 15 min. After addition NP-40 to 10%,Experimental Procedures
cells were vortexed briefly and spun for 30 s at 4	C. The nuclear
pellets were resuspended in Buffer C, rocked for 15 min at 4	C, andConstruction of Retroviral Vectors
spun 10 min. Supernatants were run in 12% SDS-PAGE gels andThe coding sequence of PU.1 was amplified using a 5 primer con-
electroblotted onto nitrocellulose membranes. Anti-mouse PU.1/taining an EcoRI restriction enzyme site, a consensus Kozak se-
Spi-1(T21)X (sc-352X) or anti-mouse SP1(PEP2)X (sc-059X, Santaquence, and the first six codons of PU.1 (CAGAATTCCACCATGTTA
Cruz Biotechnology) antibodies followed by anti-rabbit horseradishCAGGCGTGCAAA) and a 3 primer containing the last four codons
peroxidase-coupled second stage reagents were used to probe theof PU.1, a stop codon, and a NotI restriction enzyme site (CAGCGG
blots, followed by ECL-Plus detection reagent (Amersham Phar-CCGCGATCAGTGGGGCGGGA). The coding sequence of HEB-Alt
macia). Blots were exposed to X-ray film.was amplified using a 5 primer containing an EcoRI site (CAGAATT
CCACCATGTACTGTGCTTATCCT) and a 3 primer containing a NotI
Fetal Thymic Organ Culture (FTOC)site (CAGCGGCCGCTTACAGATGACCCATAGG) designed as above
Fetal thymic lobes were dissected out of E15.5 C57Bl/6  DBA/2but specific for HEB-Alt. Each product was digested with EcoRI and
F2 embryos and placed onto insert filters in 6-well plates at the air-NotI, gel purified, and cloned into the pBK-CMV plasmid vector.
media interface. The lobes were cultured with 1.35 mM deoxygua-These constructs were verified by sequencing. The inserts were cut
nosine (dGuo) in DMEM-FTOC for 5–6 days, then rinsed in DMEM-out, gel purified, and cloned into the LZRS IRES-GFP bicistronic
FTOC twice for 1 hr each just before use. Sorted GFP fetal liverretroviral vector (Heemskerk et al., 1997). Some early experiments
precursors were aliquotted in DMEM-FTOC at 10,000 cells/well inwere done with a PU.1 clone encoding a change in one noncon-
Terasaki plates, and 1 dGuo-treated lobe per well was added. Theserved amino acid, but in direct comparison, this form of PU.1 had
cells and lobes were incubated for 48 hr as hanging drop cultures.identical effects to the wild-type PU.1.
After 48 hr, the lobes were removed, rinsed in medium, and cultured
on insert filters in 6-well plates in DMEM-FTOC for 1–2 weeks.Retroviral Transduction of PU.1 and HEB
into Hematopoietic Precursors
Detailed explanation of the retroviral expression system in fetal thy- High-Oxygen Submersion FTOC and Rescue HOS
The high-oxygen submersion cultures were done as previously de-mic organ culture is available in our laboratory. Retroviral vector
DNA was transfected intoφNX-Eco packaging cells using the Effec- scribed (Kawamoto et al., 1997). Sorted GFP fetal liver precursors
in DMEM-FTOC supplemented with SCF (2% BHK-MKL superna-tene method (Qiagen, Chatsworth, CA). Transfected cells were
grown in Iscove’s Modified Dulbecco’s Medium (IMDM) supple- tant), 25 ng/mL IL-7, and 3 ng/mL IL-3 were placed into 96-well
V-bottom plates at 10,000 cells/well in 200 
l/well. Fetal lobes thatmented with 8% fetal bovine serum (FBS), 100 unit/mL penicillin,
100 
g/mL streptomycin, and 1X L-glutamine (IMDM/8%FCS), and had been dGuo-treated and rinsed were placed in each well, and
the plates were spun for 5 min. The cells were placed in an incubationtransfectants were selected using 1–10 
g/mL puromycin. For su-
pernatant collection, the puromycin was removed, and the cells chamber (Billups-Rothenberg, Inc., Del Mar, CA), flushed with the
high-oxygen gas mixture (70% O2/25% N2/5% CO2), and culturedwere cultured for 24 hr in IMDM/10% FBS. Supernatant was col-
Stage-Specific Block of T Cell Development by PU.1
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for 5 days. After 5 days, half the medium was removed from the top origins of lymphoid cell lineages? Curr. Top. Microbiol. Immunol.
248, 137–155.of the well and replaced with DMEM-FTOC supplemented with IL-7
and IL-3 only. The lobes were cultured an additional 4 days in the Anderson, M.K., Hernandez-Hoyos, G., Diamond, R.A., and Roth-
high-oxygen gas mixture and analyzed after 9 days in culture. enberg, E.V. (1999). Precise developmental regulation of Ets family
For the rescue experiments, sorted GFP fetal liver precursors transcription factors during specification and commitment to the
were placed in hanging drop culture with dGuo-treated lobes for 48 T cell lineage. Development 126, 3131–3148.
hr, then transferred into conventional FTOC for 5 days. After 5 days,
Behre, G., Whitmarsh, A.J., Coghlan, M.P., Hoang, T., Carpenter,
the lobes were placed 1 per well in 96-well round-bottom plates in
C.L., Zhang, D.E., Davis, R.J., and Tenen, D.G. (1999). c-Jun is a
200 
l of DMEM-FTOC supplemented with IL-7 and IL-3. The lobes
JNK-independent coactivator of the PU.1 transcription factor. J.
were cultured in an incubation chamber flushed with the high-oxy-
Biol. Chem. 274, 4939–4946.
gen gas mixture as before, and cultured for 10 days. After 6 days,
Carleton, M., Ruetsch, N.R., Berger, M.A., Rhodes, M., Kaptik, S.,the lobes were fed with DMEM-FTOC/IL7/IL3 as above.
and Wiest, D.L. (1999). Signals transduced by CD3, but not by
surface pre-TCR complexes, are able to induce maturation of an
FACS Analysis early thymic lymphoma in vitro. J. Immunol. 163, 2576–2585.
Thymic lobes were digested in 1 mg/mL T4 collagenase for 2 hr at
Chen, H., Ray-Gallet, D., Zhang, P., Hetherington, C.J., Gonzalez,37	C and manually disrupted by pipetting to disaggregate the cells.
D.A., Zhang, D.E., Moreau-Gachelin, F., and Tenen, D.G. (1995).Cells were stained with antibodies as previously described (Ander-
PU.1 (Spi-1) autoregulates its expression in myeloid cells. Oncogeneson et al., 1999). Stained cells were analyzed using a FACSCalibur
11, 1549–1560.(Becton-Dickinson), and the data was analyzed using CellQuest.
DeKoter, R.P., and Singh, H. (2000). Regulation of B lymphocyte
and macrophage development by graded expression of PU.1. Sci-Quantitative Real-Time PCR Expression Analysis
ence 288, 1439–1441.Total cellular RNA was extracted from sorted cell samples (20,000–
Eisenbeis, C.F., Singh, H., and Storb, U. (1995). Pip, a novel IRF200,000 cells/sample) using the RNAzolB reagent (Leedo Medical
family member, is a lymphoid-specific, PU.1-dependent transcrip-Inc., Houston, TX) and reverse transcribed as previously described
tional activator. Genes Dev. 9, 1377–1387.(Anderson et al., 1999). cDNA reactions were diluted 1/100 in 10
mM Tris, (pH 8.0), and used as templates in real-time PCR reactions Fisher, R.C., and Scott, E.W. (1998). Role of PU.1 in hematopoiesis.
using the SYBRGreen Universal Master Mix (PE Biosystems, Foster Stem Cells 16, 25–37.
City, CA), and specific primer pairs at 5 
M each. Reactions were Heemskerk, M.H., Blom, B., Nolan, G., Stegmann, A.P., Bakker, A.Q.,
run and analyzed using the GeneAmp 7700 sequence detection Weijer, K., Res, P.C., and Spits, H. (1997). Inhibition of T cell and
system (PE Biosystems). Primer sequences are as follows (5 to 3): promotion of natural killer cell development by the dominant nega-
PU.1-499 CCCGGATGTGCTTCCCTTAT and PU.1-619 TCCAAGCC tive helix loop helix factor Id3. J. Exp. Med. 186, 1597–1602.
ATCAGCTTCTCC; Rag2-903 ACAGTCTTGCCAGGAGGAATCTC
Hohaus, S., Petrovick, M.S., Voso, M.T., Sun, Z., Zhang, D.E., and
and Rag2-1023 CAAGGCTGCAGACCATCCTT; Rag1-2249 GAAGC
Tenen, D.G. (1995). PU.1 (Spi-1) and C/EBP regulate expression
TTCTGGCTCAGTCTACATCT and Rag1-2370 ACCTCATAGCGCTG
of the granulocyte-macrophage colony-stimulating factor receptor
CAGGTT; pT-204 CTGGCTCCACCCATCACACT and pT-324
alpha gene. Mol. Cell. Biol. 15, 5830–5845.
TGCCATTGCCAGCTGAGA; CD11b-2215 AATCAGGGCGCTGTC
Ikawa, T., Kawamoto, H., Fujimoto, S., and Katsura, Y. (1999). Com-TACATTTT and CD11b-2335 TCAGAGACTGCCCGAAGTACTG; Id2-
mitment of common T/natural killer (NK) progenitors to unipotent T310 CCGCTGACCACCCTGAAC and Id2-381 ATAAGCTCAGAAGG
and NK progenitors in the murine fetal thymus revealed by a singleGAATTCAGATG. PCR products as detected by SYBR green were
progenitor assay. J. Exp. Med. 190, 1617–1626.compared to a standard curve for each primer combination gener-
Kawamoto, H., Ohmura, K., and Katsura, Y. (1997). Direct evidenceated using serial 10-fold dilutions of a positive cDNA sample. Each
for the commitment of hematopoietic stem cells to T, B and myeloidsample was amplified with rodent GAPDH primers (PE Biosystems),
lineages in murine fetal liver. Int. Immunol. 9, 1011–1019.and these values were used to normalize all other results. The high-
est value in each panel of Figure 7C was arbitrarily set at 10, and Kodandapani, R., Pio, F., Ni, C.Z., Piccialli, G., Klemsz, M.,
all other relative values within each panel were adjusted accordingly. McKercher, S., Maki, R.A., and Ely, K.R. (1996). A new pattern for
helix-turn-helix recognition revealed by the PU.1 ETS-domain-DNA
complex. Nature 380, 456–460.Acknowledgments
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